Individuals with schizophrenia have an increased incidence of the H2R649G allele for the histamine H2 receptor gene

Molecular Psychiatry

Volumn 1, Issue 6, 1996, Pages 466-469

  Orange, P R ^a   Heath, P R ^b   Wright, S R ^a,b   Ramchand, C N ^a,b   Kolkeiwicz, L ^c   Pearson, R C A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

^c Claybury Hospital   (United Kingdom)

Author keywords

Monoamine; Polymerase chain reaction

Indexed keywords

ENDODEOXYRIBONUCLEASE TAQI; HISTAMINE H2 RECEPTOR; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ALLELE; ARTICLE; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SINGLE STRAND CONFORMATION POLYMORPHISM;

ALLELES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; GENOTYPE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, HISTAMINE H2; SCHIZOPHRENIA;

EID: 0030322906     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sarkar G, Kapelner S, Grandy DK, Marchionni M, Civelli O, Sobell J, Heston L, Sommer SS. Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 1991; 11: 8-14.
2. Daniels J, Williams R, Mant P, McGuffin P, Owen MJ. Repeat length variation in the dopamine D4 receptor gene shows no evidence of association with schizophrenia. Am J Med Gen (Neuropsych Gen) 1994; 54: 256-258.
3. Shaikh S, Collier D, Gill M, Pilowsky L, McMillan AM, Sham P, Kerwin R. D4 Polymorphism in schizophrenics treated with clozapine. Schiz Res 1994; 11: 146.
4. Arranz MJ, Aitchinson KJ, Kerwin R, Collier DA. Analysis of clozapine response and the 5-HT2 gene. Schiz Res 1995; 15: 35.
5. Arranz MJ, Collier DA, Sodhi M, Ball D, Roberts G, Price J, Sham P, Kerwin R. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 1995; 346: 281-282.
6. Shaikh S, Collier DA, Kerwin R. Homozygosity at the DRD3 does not influence response to clozapine. Schiz Res 1995; 15: 48.
7. 1C receptor gene and schizophrenia. Schiz Res 1995; 15: 49-50.
8. Kaminsky R, Moriarty TM, Bodine J, Wolf DE, Davidson M. Effect of famotidine on deficit symptoms of schizophrenia. Lancet 1990; 335: 1351-1352.
9. Deutsch SI, Rosse RB, Kendrick KA, McCarthy FM, Collins JP Jr, Wyatt RJ. Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary data. Clin Neuropharmacol 1993; 16: 518-524.
10. Oyewumi LK, Vollick D, Merskey H, Plumb C. Famotidine as an adjunct treatment of resistant schizophrenia. J Psychiatry Neurosci 1994; 19: 145-150.
11. Rosse RB, Kendrick K, Tsui LC, McCarthy FM, Collins JP Jr, Rosenberg P, Wyatt RJ, Deutsch SI. Famotidine adjunctive pharmacotherapy of schizophrenia: a case report. Clin Neuropharmacol 1995; 18: 369-374.
12. Whiteford HA, Stedman TJ, McGrath JJ, Welham J, Pond S, Oyewumi LK. An open-label study of famotidine as a treatment for schizophrenia. J Psych Neurosci 1995; 20: 239-240.
13. Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, Wyatt RJ. Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schiz Res 1995; 14: 93-104.
14. 1 receptors in the frontal cortex of brains from patients with chronic schizophrenia. Biol Pysch 1991; 30: 349-356.
15. Schwartz J-C, Arrang J-M, Garbarg M, Pollard H, Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 1991; 71: 1-51.
16. Arrang J-M. Pharmacological properties of histamine receptor subtypes. Cell Moll Biol 1994; 40: 273-279.
17. Coruzzi G, Adami M, Pozzoli C, Poli E, Bertaccini G. Activity of the new histamine H2-receptor antagonist Zolantidine at cardiac and gastric receptors. Pharmacology 1994; 48: 69-76.
18. 2+], signaling systems. Am J Physiol 1992; 263: (Gastrointest Liver Physiol 26): G967-G972.
19. Nishi T, Koike T, Oka T, Maeda M, Futai M. Identification of the promoter region of the histamine H2-receptor gene. Biochem Biophys Res Commun 1995; 210: 616-623.
20. Owen MJ, Mullan MJ. Molecular genetic studies of manicdepression and schizophrenia. TINS 1990; 13: 29-31.
21. Orange PR, Heath PR, Wright SR, Pearson RCA. Allelic variations of the histamine H2 receptor gene. Neuroreport 1996; 7: 1293-1296.
22. Gantz I, Munzert G, Tashiro T, Schaffer M, Wang L, DelValle J, Yamada T. Molecular cloning of the human histamine H2 receptor. Biochem Biophys Res Commun 1991; 178: 1386-1392.
23. Sambrook J, Fritsch EF, Maniatis T. Isolation of DNA from mammalian cells: protocol I. In: Sambrook J, Fritsch EF, Maniatis T (eds). Molecular Cloning, A Laboratory Manual (2nd edn). Coldspring Harbor Press: Coldspring Harbor, 1989, pp 9.16-9.19.